Medacta Group S.A.
MEDGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.08 | -1.57 | 0.09 | -0.55 |
| FCF Yield | 1.23% | 1.55% | -0.46% | 0.36% |
| EV / EBITDA | 16.92 | 28.23 | 22.93 | 35.27 |
| Quality | ||||
| ROIC | 8.59% | 3.69% | 5.73% | 4.23% |
| Gross Margin | 68.32% | 66.80% | 68.50% | 67.28% |
| Cash Conversion Ratio | 1.22 | 1.87 | 1.10 | 2.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 23.05% | 21.56% | 20.58% | 17.57% |
| Free Cash Flow Growth | -30.36% | 449.43% | -232.06% | 12,523.26% |
| Safety | ||||
| Net Debt / EBITDA | 2.28 | 3.24 | 2.77 | 3.76 |
| Interest Coverage | 13.60 | 3.47 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.41 | 0.43 | 0.41 | 0.39 |
| Cash Conversion Cycle | 209.35 | 211.06 | 210.85 | 221.67 |